Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Asher Bio
AddedMar 17, 2024
UpdatedJun 18, 2026
Asher Bio

Asher Bio

Asher Bio crafts targeted immunotherapies for cancer and diseases, focusing on precision and innovation.

HQ
South San Francisco, CA, US
Founded
2019
Accelerator
Y Combinator logoY CombinatorS19
Overview
Compare
Fundraising
Employees
Website

Asher Bio, founded with the mission to revolutionize immunotherapy, focuses on developing precisely targeted treatments for cancer and other diseases. Utilizing their innovative cis-targeting platform, Asher Bio aims to selectively activate specific immune cell types, thereby overcoming the limitations of traditional immunotherapies that affect multiple cell types indiscriminately. This approach is designed to enhance therapeutic efficacy while minimizing side effects, positioning Asher Bio at the forefront of next-generation immunotherapy solutions.

Notable figures affiliated with Asher Bio include experts in biotechnology and immunotherapy, although specific names are not provided. The company has garnered attention and investment from leading biotech investors, reflecting confidence in its groundbreaking approach. Key achievements include the development of their proprietary cis-targeting platform and significant progress in preclinical studies. Asher Bio's impact lies in its potential to offer more effective and safer treatment options for patients with cancer and autoimmune diseases, marking a significant advancement in the field of immunotherapy.

Asher Bio - Similar Companies

Asylia Therapeutics logo

Asylia Therapeutics

asyliatx.com

Cartography Biosciences logo

Cartography Biosciences

cartography.bio

Larkspur Biosciences logo

Larkspur Biosciences

larkspur.bio

HI-Bio logo

HI-Bio

hibio.com

A2 Biotherapeutics logo

A2 Biotherapeutics

a2bio.com

ArsenalBio logo

ArsenalBio

arsenalbio.com

Shasqi logo

Shasqi

shasqi.com

Immpact Bio logo

Immpact Bio

immpact-bio.com

Guardian Bio logo

Guardian Bio

guardian-bio.com

3T Biosciences logo

3T Biosciences

3tbiosciences.com

Tizona Therapeutics logo

Tizona Therapeutics

tizonatx.com

ImmunoGenesis logo

ImmunoGenesis

immunogenesis.com

BioEclipse Therapeutics logo

BioEclipse Therapeutics

bioeclipse.com

Surge Therapeutics logo

Surge Therapeutics

surgetx.com

Duet BioTherapeutics logo

Duet BioTherapeutics

Asher Bio - Quick Facts

Who are Asher Bio's competitors?

Companies similar to Asher Bio include Asylia Therapeutics, Cartography Biosciences, Larkspur Biosciences and HI-Bio.

When was Asher Bio founded?

Asher Bio was founded in 2019.

Where is Asher Bio's headquarters located?

Asher Bio's headquarters is located in South San Francisco, CA, US.

When was Asher Bio's last funding round?

Asher Bio's most recent funding round was for $108M (USD) in September 2021.

How much has Asher Bio raised to-date?

As of Sep 1, 2021, Asher Bio has raised a total of $163.2M (USD).

How many employees does Asher Bio have?

Asher Bio has 56 employees as of Feb 5, 2024.

Asher Bio - Classification

Ownership
  • Private Equity
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Cancer Treatment
  • Immunotherapy
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified